Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
17%
OVERLAP
BY WEIGHT
33
# OF OVERLAPPING
HOLDINGS
IBB
256
HOLDINGS
15%
ALSO IN CANC
CANC
48
HOLDINGS
69%
ALSO IN IBB
SECTOR DRIFT (IBB minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
AMGEN INC | 7.4% | 3.3% | 3.3% |
|
BEIGENE LTD. SPONSORED ADR | 1.6% | 2.6% | 1.6% |
 |
ARGENX SE ADR | 2.5% | 1.5% | 1.5% |
|
GILEAD SCIENCES INC | 7.7% | 1.4% | 1.4% |
|
REGENERON PHARMACEUTICALS | 6.4% | 1.4% | 1.4% |
IBB Overweight Relative to CANC
|
VERTEX PHARMACEUTICALS INC | 7.7% |
|
GILEAD SCIENCES INC | 6.3% |
|
REGENERON PHARMACEUTICALS | 5.0% |
|
ALNYLAM PHARMACEUTICALS INC | 4.7% |
|
AMGEN INC | 4.1% |
|
IQVIA HOLDINGS INC | 3.2% |
 |
METTLER-TOLEDO INTERNATIONAL | 2.9% |
|
NATERA INC | 2.6% |
|
WATERS CORP | 2.5% |
|
BIOGEN IDEC INC | 2.2% |
IBB Underweight Relative to CANC
|
ROCHE HOLDINGS LTD-SPONS ADR | -5.3% |
|
ELI LILLY & CO | -5.2% |
|
NOVARTIS AG | -4.4% |
|
REVOLUTION MEDICINES, INC. | -4.2% |
 |
ASTRAZENECA PLC | -4.1% |
|
BRIDGEBIO PHARMA, INC. | -4.0% |
|
BRISTOL-MYERS SQUIBB CO | -3.5% |
 |
MERUS N.V. | -3.4% |
|
NUVALENT, INC. CLASS A | -3.1% |
|
SUMMIT THERAPEUTICS INC | -2.8% |